The cellular neurobiology of depression
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Major depressive disorders, long considered to be of neurochemical origin, have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways may hold promise as new therapeutics for depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity that putatively mediates depressive symptoms (Drevets et al, 2002a), or by enhancing the expression of neurotrophic factors that protect medial network function from the effects of repeated stress (Manji et al, 2001).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Manji et al, 2001
In the citing paper
“Somatic antidepressant therapies may compensate for this dysfunction by modulating the pathological limbic activity which putatively mediates depressive symptoms (Drevets et al. 2002a) and the expression of neurotrophic/neuroprotective factors that preserve the function of the MPFC (Manji et al. 2001).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Manji et al. 2001
In the citing paper
“Depression is often associated with elevated HPA axis activity and increased levels of glucocorticoids, as well as disruption of negative feedback mechanisms21–23.”
From Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (2016) · cites this paper as [22]
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“However, the demonstration that neurogenesis occurs in the adult human brain into senescenc”
BackgroundThe Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332 · cited 1×
“Modest changes in this signaling cascade or in the levels of the Bcl-2 family of proteins (potentially due to genetic, illness or insult-related factors) could therefore profoundly affect cellular viabilit”
BackgroundGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“It is thus not altogether surprising that the Global Burden of Disease Study has identified MDDs among the leading causes of disability worldwide, and as illnesses likely to represent an increasingly greater health, societal and economic problem in the coming year”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Current research is examining the potential efficacy of antagonists of corticotropin-releasing factor (CRF), antiglucocorticoids and direct and indirect glutamate antagonist”
BackgroundSelf-citationChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“These studies demonstrate that chronic administration of different classes of antidepressants increases the proliferation and survival of new neuron”
BackgroundPsychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Moreover, lithium also inhibits the activity of glycogen synthase kinase 3β (GSK-3β”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“have demonstrated that an important pathway involved in cell survival and plasticity, the cAMP–CREB cascade, is up-regulated by antidepressant treatmen”
BackgroundTHE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Thus, although MDDs undoubtedly have a strong genetic basis, severe stressors have been associated with a substantial increase in risk for the onset of MDDs in susceptible individuals ( Table 3”
Background
Research works printed but not linked: 4
- Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348–364 (Oxford Press, New York, 1999).
- Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394–418 (Oxford Press, New York, 1999).
- LeDoux, J.E. Emotion. in Handbook of Physiology—The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373–417 (Williams & Wilkins, Baltimore, 1987).
- Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129–177 (American Psychiatric Press, Washington, DC, 2000).
Cited by
Items 501–600 of 1,000
Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice
Wang, J., Flaisher-Grinberg, S., Li, S., Liu, H., Sun, L., Zhou, Y., & Einat, H. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.07.042 · Cited by 50
Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania
Frey, B. N., Andreazza, A. C., Rosa, A. R., Martins, M. R., Valvassori, S. S., Réus, G. Z., Hatch, J. P., Quevedo, J., & Kapczinski, F. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000205013.59455.09 · Cited by 46
“Anatomical and functional neuroimaging findings have suggested that the interconnection between cortical and limbic structures, mainly the prefrontal cortex, amygdala and hippocampus, may be altered in mood-disordered subjects (Soares and Mann, 1997; Manji et al., 2001).”
BackgroundKoch, K., Wagner, G., Schachtzabel, C., Peikert, G., Schultz, C. C., Sauer, H., & Schlösser, R. G. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.02.002 · Cited by 45
Antidepressant-like effects of selegiline in the forced swim test
Shimazu, S., Minami, A., Kusumoto, H., & Yoneda, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.003 · Cited by 47
Chronic Clomipramine Treatment Reverses Core Symptom of Depression in Subordinate Tree Shrews
Wang, J., Chai, A., Zhou, Q., Lv, L., Wang, L., Yang, Y., & Xu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080980 · Cited by 45
“It is also a neuropsychiatric syndrome characterized by impaired structural and synaptic plasticity as well as neuronal damage [1].”
BackgroundYang, D., Liu, X., Zhang, R., Cheng, K., Mu, J., Fang, L., & Xie, P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.08.046 · Cited by 45
Bersani, F. S., Minichino, Capra, Bonanno, Pannese, Salviati, Chiaie, D., & Biondi (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s27025 · Cited by 42
Vagus nerve stimulation: mood and cognitive effects
Schachter, S. C. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.007 · Cited by 45
“007 tures involved in regulation of mood and cognition [1– 3].”
BackgroundLai, M. K. P., Tsang, S. W. Y., Esiri, M. M., Francis, P. T., Wong, P. T. ‐., & Chen, C. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1936-2 · Cited by 52
“Both pre-clinical and clinical studies have pointed to important roles of the hippocampal serotonergic system in cognitive function as well as in mood states, including depression and anxiety (Graeff et al. 1996; File et al. 2000; Manji et al. 2001; Santarelli et al. 2003).”
BackgroundPryce, C. R., & Seifritz, E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.05.003 · Cited by 52
“…in the central nervous system, involving: decreased glucose transport, increased glutamate signalling, decreased brain-derived neurotrophic factor, and decreased mitogen-activated protein kinase (MAPK) signalling, leading to impaired cellular resilience (Duman et al., 1997; Manji et al., 2001).”
Ai, H., Fang, W., Hanyi, H., Xupang, H., & Lu, W. (2020) · Aging and Disease · doi:10.14336/ad.2019.0403 · Cited by 46
“Chronic stress causes pathophysiological and psychological alterations associated with mental illness, leading to neuropsychiatric disorders including depression [1-3].”
BackgroundGene expression patterns in brain cortex of three different animal models of depression
Urigüen, L., Arteta, D., Díez-Alarcia, R., Ferrer‐Alcón, M., Díaz, Á., Pazos, Á., & Meana, J. J. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00402.x · Cited by 48
“Structural alterations have been described in different brain areas, such as the anterior cingulate, dorsolateral and prefrontal cortices, which are characterized by decreases in glial cell number or density (Manji et al. 2001).”
BackgroundUmene‐Nakano, W., Yoshimura, R., Ikenouchi‐Sugita, A., Hori, H., Hayashi, K., Ueda, N., & Nakamura, J. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1035 · Cited by 44
“Depressed patients exhibit pathological changes in specific brain areas, including the limbic (hippocampus and amygdale) and cortical brain regions (Drevetz et al., 1997; Bremner et al., 2000; Manji et al., 2001; Mervaala et al., 2000).”
BackgroundWard, M. P. (2010) · Frontiers in Neuroengineering · doi:10.3389/fneng.2010.00007 · Cited by 43
“…Neuroengineering www.frontiersin.org May 2010 | Volume 3 | Article 7 | 1 NEUROENGINEERING Review ARticle published: 31 May 2010 doi: 10.3389/fneng.2010.00007 persists for up to a year (Judd et al., 1998), significantly impairing the health and daily activities of the afflicted (Manji et al., 2001).”
InfluentialKordjazy, N., Haj‐Mirzaian, A., Amiri, S., Ostadhadi, S., Amini-Khoei, H., & Dehpour, A. R. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.11.009 · Cited by 44
“Discovery of the antidepressant effect of NMDA receptor antagonists has linked the glutamatergic pathway to the pathophysiology of depression (Manji et al., 2001) and the mechanism of action of some antidepressants (Berman et al.”
BackgroundPechnick, R. N., Chesnokova, V., Kariagina, A., Price, S., Bresee, C. J., & Poland, R. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300402 · Cited by 44
“LIF is expressed in the hypothalamus (Chesnokova and Melmed, 2000), amygdala, and hippocampus (Chesnokova et al, unpublished data), regions of the CNS that are associated with depressive and stressrelated behaviors as well as in antidepressant response (Manji et al, 2001; Davidson et al, 2002).”
BackgroundTrevizol, F., Roversi, K., Dias, V. T., Roversi, K., Pase, C. S., Barcelos, R. C. S., Benvegnú, D. M., Kuhn, F. T., Dolci, G. S., Ross, D. H., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.007 · Cited by 43
“While BD remains poorly understood, its pathophysiology has been related to processes which include failures in the neuronal plasticity and neurotransmission (Coyle and Duman, 2003; Manji et al., 2001) and inflammatory”
BackgroundNonhuman Primate Models of Depression: Effects of Early Experience and Stress
Worlein, J. M. (2014) · ILAR Journal · doi:10.1093/ilar/ilu030 · Cited by 43
Azman, K. F., Zakaria, R., AbdAziz, C., Othman, Z., & Al-Rahbi, B. (2015) · Noise and Health · doi:10.4103/1463-1741.153388 · Cited by 48
“[49,50] Hence, it is suggested that Tualang honey exhibits its antidepressive-like effects via restoration of HPA axis and enhancement of brain BDNF concentration.”
Al-Rahbi, B., Zakaria, R., Othman, Z., Hassan, A., & Ahmad, A. H. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/310821 · Cited by 45
Miguel-Hidalgo, J. J., Whittom, A., Villarreal, A., Soni, M., Meshram, A., Pickett, J. C., Rajkowska, G., & Stockmeier, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.010 · Cited by 42
“…to the pathology of depression could be a major immediate cause for increased cellular vulnerability to damage or slow depletion of cell numbers (Manji et al., 2001, 2000) This study examined levels of apoptosis-promoting proteins caspase 8 (C8) and direct IAP binding protein with low pI…”
BackgroundEffects of Duloxetine in Treatment-Refractory Men with Posttraumatic Stress Disorder
Walderhaug, E., Kasserman, S., Aikins, D., Vojvoda, D., Nishimura, C., & Neumeister, A. (2010) · Pharmacopsychiatry · doi:10.1055/s-0029-1237694 · Cited by 41
Tagliari, B., dos Santos, T. M., da Cunha, A. A., de Lima, D. D., Delwing, D., Sitta, Â., Vargas, C. R., Dalmaz, C., & Wyse, Â. T. D. S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0445-0 · Cited by 44
“It has been demonstrated that depression arises from the complex interaction of multiple susceptible (and likely protective) genes and environmental factors, and disease phenotypes include not only episodic and often profound mood disturbances, but also a range of cognitive, motoric, autonomic, endocrine, and sleep/wa…”
Stone, E. A., Lehmann, M. L., Lin, Y., & Quartermain, D. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.04.010 · Cited by 49
“It is generally recognized that depression is a multifactorial disorder with genetic, developmental and experiential causes (Manji et al., 2001; Nemeroff, 2002).”
Backgrounddo-Rego, J.-C., Benkiki, N., Chosson, E., Kabouche, Z., Seguin, E., & Costentin, J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.008 · Cited by 41
Antidepressant-like activity of plumbagin in unstressed and stressed mice
Dhingra, D., & Bansal, S. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.001 · Cited by 45
Kuo, J., Cheng, Y.-H., Chen, Y.-S., Chio, C., & Gean, P. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2689 · Cited by 42
Implications of Efavirenz for Neuropsychiatry: A Review
Cavalcante, G. I. T., Capistrano, V. L. M., Cavalcante, F. S., Vasconcelos, S. M. M., Macêdo, D. S., de Sousa, F. C. F., Woods, D. J., & Fonteles, M. M. D. F. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.520541 · Cited by 52
Omata, N., Murata, T., Takamatsu, S., Maruoka, N., Mitsuya, H., Yonekura, Y., Fujibayashi, Y., & Wada, Y. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00521.x · Cited by 41
Real, E., Gratacòs, M., Soria, V., Escaramís, G., Alonso, P., Segalàs, C., Bayés, M., de Cid, R., Menchón, J. M., & Estivill, X. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.017 · Cited by 45
Guirado, R., Varea, E., Castillo-Gómez, E., Gómez‐Climent, M. Á., Rovira-Esteban, L., Blasco‐Ibáñez, J. M., Crespo, C., Martinez-Guijarro, F. J., & Nácher, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.104 · Cited by 48
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation
Tiraboschi, E., Giambelli, R., DʼUrso, G., Galietta, A., Barbon, A., de Bartolomeis, A., Gennarelli, M., Barlati, S., Racagni, G., & Popoli, M. (2004) · NeuroReport · doi:10.1097/00001756-200410250-00018 · Cited by 41
“INTRODUCTION Although pharmacotherapy of affective disorders dates back four decades, recent research showed that antidepressant drug action is more complex than described earlier, involving mechanisms of neuroplasticity and cellular resilience [1].”
BackgroundPraschak-Rieder, N., Hussey, D., Wilson, A. A., Carella, A., Lee, M., Dunn, E. J., Willeit, M., Bagby, R. M., Houle, S., & Meyer, J. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.018 · Cited by 45
Law, A. J., Pei, Q., Feldon, J., Pryce, C. R., & Harrison, P. J. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009723 · Cited by 43
Frisardi, V., Panza, F., & Farooqui, A. A. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.04.003 · Cited by 51
Young Women With Major Depression Live on Higher Homeostatic Sleep Pressure Than Healthy Controls
Frey, S., Birchler-Pedross, A., Hofstetter, M., Brunner, P., Götz, T., Münch, M. Y., Blatter, K., Knoblauch, V., Wirz‐Justice, A., & Cajochen, C. (2012) · Chronobiology International · doi:10.3109/07420528.2012.656163 · Cited by 44
“Compelling evidence has accumulated for an impairment of structural and functional brain plasticity associated with the pathophysiology of major depression (Duman et al., 2000; Krishnan & Nestler, 2008; Manji et al., 2001; Pittenger & Duman, 2008).”
BackgroundPinna, G., Brödel, O., Eravci, M., Stoltenburg, G., Plueckhan, H., Fuxius, S., MEINHOLD, H., & Baumgartner, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00414-1 · Cited by 42
Targeting TrkB neurotrophin receptor to treat depression
Rantamäki, T., & Castrén, E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.705 · Cited by 40
“Remarkably, depression is often associated with cellular loss, atrophy and abnormal neuronal connectivity in many of the aforementioned brain areas [3,8,11-13] .”
Backgroundm‐Chlorophenylpiperazine exacerbates perception of salicylate‐induced tinnitus in rats
Guitton, M. J., Pujol, R., & Puel, J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04436.x · Cited by 40
“Of these, serotonin is thought to play a major role (Lesch et al., 1996; Ramboz et al., 1998; Manji et al., 2001; Snyder, 2002).”
BackgroundAllaman, I., Papp, M., Kraftsik, R., Fiumelli, H., Magistretti, P. J., & Martin, J. (2008) · PubMed · Cited by 44
Tsiouris, J. A. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.05.044 · Cited by 48
“Many of these hypotheses describe the effects of psychotropics with antidepressant qualities on the physiology and neurochemistry of the brain at different levels or have documented state-dependent abnormalities, but they do not explain the neurobiology of depressive disorders [2–4].”
BackgroundAsgharian, P., Quispe, C., Herrera‐Bravo, J., Sabernavaei, M., Hosseini, K., Forouhandeh, H., Ebrahimi, T., Sharafi-Badr, P., Tarhriz, V., Soofiyani, S. R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.926607 · Cited by 52
“The physiopathology of the disease is not yet clear, but it is associated with abnormalities in the brain’s monoamine receptors or neurotransmitters, metinflammation conditions and as well as the serotonergic, noradrenergic, and neuropeptide systems are abnormal (Manji et al., 2001; Charney and Manji, 2004).”
BackgroundTest–retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943
Sarıçiçek, A., Chen, J., Planeta, B. M., Ruf, B. M., Subramanyam, K., Maloney, K. H., Matuskey, D., Labaree, D. C., Deserno, L., Neumeister, A., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2958-5 · Cited by 40
Frøkjær, V. G., Erritzøe, D., Holst, K. K., Jensen, P. S., Rasmussen, P. M., Fisher, P. M., Baaré, W. F. C., Madsen, K. S., Madsen, J., Svarer, C., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.013 · Cited by 41
“This provides a plausible mechanism by which environmental stress in combination with inherited vulnerability may lead to mood disorders since neurobiological consequences of stress (Holsboer, 2001; Ising et al., 2005; Manji et al., 2001; Mannie et al., 2007), play a role in the pathophysiology.”
Pesarico, A. P., Sampaio, T. B., Stangherlin, E. C., Mantovani, A. C., Zeni, G. R., & Nogueira, C. W. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.06.001 · Cited by 40
“It affects approaching 15%–25% of the population (Nemeroff, 2007) and studies predict that in 2020, it will be the second largest global burden of disease, illustrating the severity and impact of the disorder (Manji et al., 2001).”
BackgroundPTEN in prefrontal cortex is essential in regulating depression-like behaviors in mice
Wang, X.-Q., Zhang, L., Xia, Z., Chen, J., Fang, Y., & Ding, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01312-y · Cited by 44
Erburu, M. M., Cajaleon, L., Guruceaga, E., Vénzala, E., Muñoz-Cobo, I., Beltrán, E., Puerta, E., & Tordera, R. M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.001 · Cited by 43
“…induced by antidepressants do not correspond with the requirement of two to three weeks of drug treatment for the therapeutic effects (Duman et al., 1997, 1999; Manji et al., 2001; ild stress; EPM, elevated plus r models for microarray data; y, University of Navarra, 31008 Nestler et al., 2002).”
Bachatene, L., Bharmauria, V., Cattan, S., & Molotchnikoff, S. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12206 · Cited by 45
“It has been suggested that this dual modulation is attributed to a push–pull mechanism (Palmer & Davis, 1981; Ferster, 1988, 1992; Tolhurst & Dean, 1990; Troyer et al., 1998; Shapley et al., 2003; Ghisovan et al., 2009), which appears to be sensitive to SSRIs.”
BackgroundInfluentialZavvari, F., Nahavandi, A., & Goudarzi, M. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.101711 · Cited by 38
Wang, C., Zhang, J., Yang, L., Lin, P., Pan, T., Zhao, X., Liu, A., Wang, Q., Zhou, W., & Zhang, H. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9533-4 · Cited by 45
“Although many experimental and clinical studies clearly implicate the involvement of monoamines in pathophysiology of depressive disorders, the monoaminergic hypothesis does not provide sufficient explanations for the mechanisms underlying the development of depression and actions of a variety of antidepressant drugs…”
BackgroundRegulation of Neuronal Stem Cell Proliferation in the Hippocampus by Endothelial Ceramide
Gulbins, A., Grassmé, H., Hoehn, R. S., Wilker, B., Soddemann, M., Kohnen, M., Edwards, M. J., Kornhuber, J., & Gulbins, E. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447789 · Cited by 44
Chernoloz, O., El Mansari, M., & Blier, P. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110038 · Cited by 38
Pharmacogenetic considerations in the treatment of psychiatric disorders
Lohoff, F., & Ferraro, T. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903508762 · Cited by 43
“Although citalopram does not bind directly to 5-HT2A receptors, citalopram downregulates 5-HT2A receptors in animal models [34,35], which could play a role in differences in treatment response.”
BackgroundGlial degeneration as a model of depression
Śmiałowska, M., Szewczyk, B., Woźniak, M., Wawrzak-Wleciał, A., & Domin, H. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71518-4 · Cited by 41
“tered neuroplasticity, dysfunction of monoaminergic systems and genetic factors have been studied to elucidate depressive-related behaviors [31, 35].”
BackgroundWang, J., Jing, L., Toledo-Salas, J.-C., & Xu, L. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-014-1484-6 · Cited by 42
“Neurosci Bull February 1, 2015, 31(1): 75–86. http://www.neurosci.cn DOI: 10.1007/s12264-014-1484-6 75 ·Review· Rapid-onset antidepressant efficacy of glutamatergic system modulators: The neural plasticity hypothesis of depression Jing Wang1, 2, 3, Liang Jing1, 2, Juan-Carlos Toledo-Salas1, Lin Xu1, 2 1Key Laboratory…”
BackgroundInfluentialWang, K., Sun, S., Li, L., Tu, M., & Jiang, H. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.03.005 · Cited by 42
The best-laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease
Williams, A. J., & Umemori, H. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00004 · Cited by 38
“…there are data to support neuron and synapse loss in certain cortical and hippocampal areas in mood disorders like depression and bipolar disorder (Manji et al., 2001; Stockmeier et al., 2004; Stockmeier and Rajkowska, 2004), aberrant brain connectivity in autism (Chung et al., 2013; Lynch et…”
BackgroundImpact of Pharmacogenetics on CNS Side Effects Related to Efavirenz
Martín, A. S., Figueroa, S. C., Guerrero, R. C., Hurtado, L. P., Hurlé, A. D.-G., & Carracedo, Á. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.111 · Cited by 37
The Role of the PACAP Signaling System in Depression
Pinhasov, A., Nesher, E., Gross, M., Turgeman, G., Kreinin, A., & Yadid, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795589328 · Cited by 40
“[97] Manji HK, Drevets WC, Charney DS.”
BackgroundLi, W., Zhu, Y. H., Saud, S. M., Guo, Q., Xi, S., Jia, B., Jiao, S., Yang, X., Lü, J., Song, S., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.060 · Cited by 38
Recent Advances in the Neurobiology of Depression
Normann, C., & Berger, T. (2003) · CRC Press eBooks · doi:10.3109/9780203002889-3 · Cited by 37
Manji, H. K., & Zarate, C. A. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001068 · Cited by 43
Self-citationDeep Transcranial Magnetic Stimulation Using Figure-of-Eight and Halo Coils
Lu, M., & Ueno, S. (2015) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2015.2436977 · Cited by 36
Blanco, J., Mulero, M., López, M., Domingo, J. L., & Sánchez, D. J. (2011) · Toxicology · doi:10.1016/j.tox.2011.10.010 · Cited by 40
Pereira, V. S., Suavinha, A. C. D. R., Wegener, G., & Joca, S. R. L. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3853-2 · Cited by 39
Yamauchi, J., Miyamoto, Y., Torii, T., Mizutani, R., Nakamura, K., Sanbe, A., Koide, H., Kusakawa, S., & Tanoue, A. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.03.012 · Cited by 43
cAMP signaling pathway in depressed patients with psychotic features
Pérez, J., Tardito, D., Racagni, G., Smeraldi, E., & Zanardi, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000969 · Cited by 37
Gene Therapy for Psychiatric Disorders
Gelfand, Y. J., & Kaplitt, M. G. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2012.12.028 · Cited by 38
Crowding increases salivary cortisol but not self‐directed behavior in captive baboons
Pearson, B. L., Reeder, D. M., & Judge, P. G. (2015) · American Journal of Primatology · doi:10.1002/ajp.22363 · Cited by 41
“Elevations in stress hormones are implicated in depression [Manji et al., 2001] and are known to impair adult hippocampal neurogenesis [Cameron & Gould, 1994].”
BackgroundIs major depressive disorder a metabolic encephalopathy?
Harvey, B. H. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.946 · Cited by 36
“cyclic AMP response element binding protein (CREB), NO, B-cell lymphoma 2 (bcl-2), glycogen synthase kinase (GSK) and extracellular signalregulated kinase (ERK) leading to gene transcription and protein synthesis (Manji et al., 2001; D’Sa and Duman, 2002; Berton and Nestler, 2006).”
BackgroundInfluentialSoleimani, L., Roder, J., Dennis, J. W., & Lipina, T. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00358.x · Cited by 37
“Malfunction of HPA axis is associated with some subtypes of depression and may contribute to chemical imbalance and disease [reviewed in Manji et al. (2001)], but Mgat5 / mice showed normal corticosterone surge in response to acute stress.”
BackgroundPrenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex
Szymańska, M., Beroun, A., Budziszewska, B., Jaworska-Feil, L., Basta‐Kaim, A., Leśkiewicz, M., Kubera, M., Gergont, A., Kroczka, S., Kaciński, M., et al. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70113-6 · Cited by 37
“in these brain structures [5, 18].”
Liu, Q., Yu, J. M., Mao-Ying, Q.-L., Mi, W.-L., Li, B., Yq, W., Wang, J., & Wu, G. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500485 · Cited by 38
Réus, G. Z., Abelaira, H. M., Agostinho, F. R., Ribeiro, K. F., Vitto, M. F., Luciano, T. F., de Souza, C. T., & Quevedo, J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.04.016 · Cited by 39
“For example, studies related that both antidepressants and stress regulate neurotrophic factors, such as CREB and BDNF, which are both involved in cell survival pathways that control pro and antiapoptotic protein expression (Manji et al., 2001).”
BackgroundPsychiatric Disorders - Trends and Developments
(2011) · InTech eBooks · doi:10.5772/2330 · Cited by 35
Schaun Korff, A., Stein, D. J., & Harvey, B. H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.01.025 · Cited by 35
The burden of general medical conditions in patients with bipolar disorder
Kilbourne, A. M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0069-5 · Cited by 34
“More recently, evidence suggests that “allostatic load,” defined as the “wear and tear” on the body and brain resulting from chronic overactivity or inactivity of physiologic systems that are normally involved in adaptation to environmental (negative) stressors, may exacerbate the burden of medical comorbidity (Fig. 1…”
BackgroundGarbett, K. A., Vereczkei, A., Kalman, J. L., Wang, L., Korade, Ž., Shelton, R. C., & Mirnics, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.14 · Cited by 37
Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology
Bortolato, B., Berk, M., Maes, M. H. J., McIntyre, R. S., & Carvalho, A. F. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144027 · Cited by 38
Antidepressant-Like Effect of Isorhynchophylline in Mice
Xian, Y., Fan, D., Ip, S., Mao, Q., & Lin, Z. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2124-5 · Cited by 34
Kang, R.-H., Hahn, S.-W., Choi, M.-J., & Lee, M.-S. (2007) · Neuropsychobiology · doi:10.1159/000109970 · Cited by 34
“Recent investigations of antidepressant mechanisms have focused on intracellular signaling pathways controlled by the long-term administration of antidepressants [”
Li, H., Linjuan-Li, & Wang, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.123 · Cited by 35
“Numerous reports have shown that, although the etiology of depression is complex, it is associated with the lack of monoamine neurotransmitter [6], hypothalamus-pituitary-adrenocortical axis dysfunction [7], diminished neurotrophic factor expression, hippocampal neurogenesis [8] and inflammation [9,10].”
BackgroundShu, Y., & Xu, T. (2017) · Neural Plasticity · doi:10.1155/2017/6207873 · Cited by 39
“It has been shown that the alterations of activities in the medial and anterior regions of PFC are important for mediating stress-induced symptoms, such as depression [13, 14].”
Backgroundvan Gemert, N. G., & Joëls, M. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01472.x · Cited by 38
Herr, A. S., Tsolakidou, A. F., Yassouridis, A., Holsboer, F., & Rein, T. (2003) · Neuroendocrinology · doi:10.1159/000071701 · Cited by 34
Chen, P.-J., Liang, K., Lin, H., Hsieh, C., Su, K., Hung, M.-C., & Sheen, L. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2010.1209 · Cited by 34
Nowakowska, E., Kus, K., Ratajczak, P., Cichocki, M., & Woźniak, A. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.12.008 · Cited by 34
“It is known that exposure to chronic stress may affect neuronal activity, adversely affect brain function, causing impairment of cognitive functions, or development of mental disorders [14], while enriched environment has a stimulating effect on people with brain damage and the increase in the number of neurons in the…”
BackgroundMalki, K., Lourdusamy, A., Binder, E., Paya-Cano, J. L., Sluyter, F., Craig, I., Keers, R., McGuffin, P., Uher, R., & Schalkwyk, L. C. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328356fa90 · Cited by 34
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
Lotrich, F. E., & Pollock, B. G. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.1.1.17.52301 · Cited by 33
“Other potential downstream effector molecules for BDNF that may enhance neuronal survival, augment neuroplasticity, or decrease apoptosis include Bcl-2 and glycogen synthase kinase 3 (Manji et al 2001; Gould and Manji 2002; Manji and Chen 2002).”
BackgroundFarvolden, P., Kennedy, S. H., & Lam, R. W. M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.65 · Cited by 41
Liu, C., Lee, S., & Elmquist, J. K. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.02.008 · Cited by 38
Biological and Behavioral Patterns of Post-Stroke Depression in Rats
Ifergane, G., Boyko, M., Frank, D., Shiyntum, H. N., Grinshpun, J., Kuts, R., Geva, A. B., Kaplan, Z., Zeldetz, V., & Cohen, H. (2018) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2017.302 · Cited by 32
Matrisciano, F., Scaccianoce, S., Bianco, P. D., Panaccione, I., Canudas, A. M., Battaglia, G., Riozzi, B., Ngomba, R. T., Molinaro, G., Tatarelli, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03141.x · Cited by 33
Effects of Genes and Stress on the Neurobiology of Depression
Mann, J. J., & Currier, D. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)73005-7 · Cited by 37
Szegedi, V., Juhász, G., Zhang, X., Barkóczi, B., Qi, H., Madeira, A., Kapus, G. L., Svenningsson, P., Spedding, M., & Penke, B. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.10.008 · Cited by 38
“Most antidepressants alter the availability of serotonin, noradrenalin and other biogenic amines in the brain; however, this effect is unlikely to be the sole cause of the antidepressant action, but rather initiates cellular adaptations that ultimately lead to an antidepressant action (Berton and Nestler, 2006; Coyle…”
Li, H., Zhang, L., & Huang, Q. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.036 · Cited by 38
Sabater, A., García‐Blanco, A., Verdet, H. M., Sierra, P., Ribes, J., Villar, I., Lara, M. J., Arnal, P., Rojo, L., & Livianos, L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.008 · Cited by 34
“itating mental illness (Manji et al., 2001).”
Mechanisms of depression in epilepsy from a clinical perspective
Hečimović, H., Goldstein, J. D., Sheline, Y. I., & Gilliam, F. G. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.08.021 · Cited by 37
Chen, B., Jin, K., Dong, J., Cheng, S., Kong, L., Hu, S., Chen, Z., & Lü, J. (2024) · Advanced Science · doi:10.1002/advs.202405354 · Cited by 43
Regulation of Neurite Growth by Inorganic Pyrophosphatase 1 via JNK Dephosphorylation
Tezuka, Y., Okada, M., Tada, Y., Yamauchi, J., Nishigori, H., & Sanbe, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061649 · Cited by 32
“In addition, we also reported that valproic acid (VPA), a short-branched fatty acid used as a mood-stabilizing agent for the treatment of manic-depressive illness (also known as bipolar disorder) and as an anticonvulsant [13,14], can promote neurite outgrowth via the JNK activation in mouse neuroblastoma N1E115 cells…”
Background
Metadata
- Authors
- Manji, H. K., Drevets, W. C., & Charney, D. S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Mental Health (US)
- Corresponding author
- Manji, Husseini K.
- Venue
- Nature Medicine
- Published
- 2001-05
- Volume
- 7
- Issue
- 5
- Pages
- 541-547
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1509868652
- Cited by
- 1,182
- References
- 66
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 20 · 2023: 21 · 2022: 33 · 2021: 55 · 2020: 29 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 36 · 2015: 51 · 2014: 50 · 2013: 60 · 2012: 60
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, neurobiology of depression, neuroplasticity, cell survival, signaling pathways
- MeSH terms
- Antidepressive Agents, Cell Survival, Depressive Disorder, Glucocorticoids, Neuronal Plasticity, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.